Milestone Pharmaceuticals
Führungskräfte
Siehe das Organigramm mit seine 18 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei Milestone Pharmaceuticals
- Joseph Oliveto, Director, President and Chief Executive Officer
- Michael Tomsicek, Director
- Debra Liebert, Director
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von Milestone Pharmaceuticals nachzuverfolgen.
Pharmazie
Milestone Pharmaceuticals hat 1.863 Konkurrenten , einschließlich Pfizer (USA), Sanofi (Frankreich) und Johnson & Johnson (USA).
Popular M&A news in Pharmazie
- AstraZeneca has announced the acquisition of Fusion Pharma (veröffentlicht am 23, März 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (veröffentlicht am 19, März 2024).
- Frontier Medicines hat gerade eine Spendenaktion von 80 Millionen Dollar angekündigt. (veröffentlicht am 27, Februar 2024).
Andere vorgeschlagene Kontakte der Pharmazie branche
Nachrichten
Neueste Pressemitteilungen nach Milestone Pharmaceuticals
- Milestone Pharmaceuticals to Present at the Jefferies Healthcare Conference | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Corporate Update | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of PSVT | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical and Corporate Update | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals to Present at Upcoming Investor Conferences | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer | Milestone Pharmaceuticals, Inc.
- View more press releases Close
Social media about Milestone Pharmaceuticals
- Milestone Pharmaceuticals auf Wikipedia, Google News & Yahoo Finance
- Milestone Pharmaceuticals auf LinkedIn, Twitter & YouTube
In Kontakt kommen
Jetzt seine Führungskräfte, darunter auch Joseph Oliveto, per E-Mail kontaktieren. 
Milestone Pharmaceuticals unter +1 514... anrufen
